| Literature DB >> 29467926 |
Rixing Jing1,2, Jiangjie Huang3, Deguo Jiang3, Xiaodong Lin3, Xiaolei Ma4, Hongjun Tian4, Jie Li5, Chuanjun Zhuo3,5.
Abstract
Schizophrenia is associated with widespread and complex cerebral blood flow (CBF) disturbance. Auditory verbal hallucinations (AVH) and insight are the core symptoms of schizophrenia. However, to the best of our knowledge, very few studies have assessed the CBF characteristics of the AVH suffered by schizophrenic patients with and without insight. Based on our previous findings, Using a 3D pseudo-continuous ASL (pcASL) technique, we investigated the differences in AVH-related CBF alterations in schizophrenia patients with and without insight. We used statistical parametric mapping (SPM8) and statistical non-parametric mapping (SnPM13) to perform the fMRI analysis. We found that AVH-schizophrenia patients without insight showed an increased CBF in the left temporal pole and a decreased CBF in the right middle frontal gyrus when compared to AVH-schizophrenia patients with insight. Our novel findings suggest that AVH-schizophrenia patients without insight possess a more complex CBF disturbance. Simultaneously, our findings also incline to support the idea that the CBF aberrant in some specific brain regions may be the common neural basis of insight and AVH. Our findings support the mostly current hypotheses regarding AVH to some extent. Although our findings come from a small sample, it provide the evidence that indicate us to conduct a larger study to thoroughly explore the mechanisms of schizophrenia, especially the core symptoms of AVHs and insight.Entities:
Keywords: auditory verbal hallucination; cerebral blood flow; insight; schizophrenia
Year: 2017 PMID: 29467926 PMCID: PMC5805512 DOI: 10.18632/oncotarget.23631
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
Demographic characteristics of the participants
| Characteristics | AVH-schizophrenic patients without insight patients | AVH-schizophrenic patients with insight patients | Healthy controls | t/F/Χ2 | |
|---|---|---|---|---|---|
| Age, years: mean (s.d.) | 33.6 ± 11.1 | 33.4 ± 10.2 | 33.6 ± 11.2 | 0.001 | 0.999 |
| Gender, femalen/male: n | 3/6 | 7/2 | 5/4 | 3.600 | 0.058 |
| Illness duration, years: mean (s.d.) | 11.4 ± 6.4 | 11.2 ± 9.8 | 0.057 | 0.955 | |
| Antipsychotic dosage, mg/d: mean (s.d.) | 374.07 (173.82) | 375.18 (201.16) | 0.011 | 0.992 | |
| PANSS, mean (s.d.) | 70.3 (14.9) | 70.4 (23.0) | 0.012 | 0.990 | |
| AHRS, mean (s.d.) | 6.77 (2.86) | 4.44 (0.52) | 2.405 | 0.029 |
Note: Antipsychotic dosages are reported as chlorpromazine equivalents calculated based on clinically equivalent dosing estimates.
Figure 1CBF alterations differences among AVH-schizophrenic patients without insight, with insight and healthy controls
The value of the CBF in the aberrant brain regions
| Patients Group | Brain regions | CBF Pseudo- |
|---|---|---|
| AVH schizophrenia patients with complete insight; | Occipital Gyrus | −4.28 |
| Middle Frontal Gyrus | −4.13, −4.31, −4.43(Three cluster) | |
| Inferior Parietal Lobule | −5.02, −4.22, −4.68 (Three cluster) | |
| Left Precentral Gyrus | −5.45 | |
| AVH schizophrenia patients without complete insight; | Superior Parietal Lobule | −5.51 |
| Postcentral Gyrus | −4.74 | |
| Inferior Parietal Lobule | −5.36 | |
| Middle Frontal Gyrus | −4.9 | |
| Left Precentral Gyrus | −4.9 | |
| AVH schizophrenia patients without complete insight; | Left temporal Pole | 4.08 |
| compared to the patients with | Right Middle Frontal Gyrus | −3.01 |